pital
Welcome to the 29th Annual Enterprise Awards.
Our region's most prestigious celebration of achievement, innovation, and success for leaders in life sciences and technology will be taking place May 24th, 2022.
NAVIGATION
CELEBRATE OUR INNOVATORS!
May 24th: IN-PERSON, 5:00 – 9:30 PM
The 2022 Enterprise Awards will take place at Springfield Country Club on May 24th with a live awards program where all of our Finalists will be featured and Winners announced. The ceremony will be followed by a celebration of our finalists and honorees on the Tavola Patio
- 5:00PM – Registration opens
- 5:30PM – Awards program begins
- 6:30PM – Outdoor networking reception and celebration
Dress code is “smart casual” (no suit, no ties, no fancy dresses).

FINALISTS
Life Sciences & Healthcare Startup
Center for Breakthrough Medicines
NeuExcell Therapeutics
Patina
Sponsor: Ben Franklin Technology Partners
Technology Startup
Formotiv
Malbek
Tendo
Sponsor: Broadpath and Troutman Pepper
Investment Deal
Boomi
Century Therapeutics
Pinnacle 21
Sponsors: Baker Tilly and Cigniti Technologies
Life Sciences & Healthcare Emerging
Carisma Therapeutics
MOBILion Systems
X-Nav Technologies
Sponsors: RSM and SAP
Technology Emerging
Circonus
DrayNow
Grovara
Sponsors: Bank of America and Fox Rothschild
Life Sciences & Healthcare CEO
Dea Belazi, AscellaHealth
Michael Daley, PhD, OrthogenRX
Martin Lehr, Context Therapeutics
Sponsors: EY and Morgan Lewis & Bockius
Technology CEO
David DeStefano, Vertex
Nader Elm, Exyn Technologies
Bob Moore, Crossbeam
Sponsor: Cozen O’Connor
Healthcare Innovator
Dina
SwanBio Therapeutics
Venatorx Pharmaceuticals
Sponsor: Independence Blue Cross
Technology Company
Clinical Ink
Piano
YPrime
Sponsor: Comcast Business
Sponsors
Title Sponsor

Judging Partner

Competitive Award Sponsors
Event Sponsors
Enterprise Sponsors
Judges
LEAD JUDGE
Rick Riegel
Chairman
ActiGraph and Deerfield
Technology Judging Panel Oversight
Andrew Cherry
Partner
KPMG
Technology Judges
Joseph Biancaniello
VP, Commercial and Technology Banking
JP Morgan
Jared Blitzstein
Director, Software Engineering
Boomi
Greg Doran
Chief Financial Officer
Frontline Education
Sean Dowling
Partner
Osage Venture Partners
Venkatesh Jayaraman
VP, Software Engineering
Vertex Inc.
Bharat Santhanam
Vice President
NewSpring Capital
Aimee Senour
Vice President, Business Development
Cigniti Technologies
Brian McCabe
Senior Director, Technology Finance
BridgeBank
Dan Klein
Managing Director
Slalom
Nassar Nizami
CIO
Jefferson University/Einstein
Pooja Ojala
Vice President, Strategy
Veeva
Daphne Thomas
Chief Operating Officer
iPipeline
Life Sciences & Healthcare Judging Panel Oversight
Jennifer Strong
Partner
KPMG
Tom Koncsics
Partner
KPMG
Life Sciences & Healthcare Judges
Kevin Brophy
Life Sciences Industry Principal
SAP
Greg Cathcart
Chief Executive Officer
Excellis Health Solutions
Victor Caraballo, MD
Vice President Quality Management
Independence Blue Cross
Gerianne DiPiano
Chief Executive Officer
FemmePharma
Lalo Flores, PhD
CEO
Century Therapeutics
Maneesh Goel
SVP, Senior Relationship Manager
Bank of America
Shahram Hejazi, PhD
Managing Director and CEO
BioAdvance
Dr. Calvin Knowlton
Chief Executive Officer
Tabula Rasa
Maria Maccecchini, PhD
CEO
Annovis Bio
Matthew Reber
Partner
1315 Capital
Heather Steinman
VP Business Development and Executive Director of Technology Transfer
The Wistar Institute
Zev Sunleaf
Vice President
Office of Technology Transfer, Commercialization & Innovation
Children’s Hospital of Philadelphia
Award Criteria
To View the Enterprise Awards Applications, please click on each award heading below.
The Deadline for Nominations was Friday, November 19th
Title Sponsor: Fairmount Partners
Judging Partner: KPMG LLP
Technology Emerging
Sponsor: Fox Rothschild LLP and Bank of America
Criteria:
- Company must have been in operation before January 1, 2018. Revenues must be less than $50 million, except in the most recent fiscal year.
Key Considerations:
- Product or service innovation, including proprietary technology or other advantage.
- Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
- Strength of management team including ability to raise capital.
- Profitability or demonstrated ability to achieve profitability (e.g. strategy to achieve break even, the ability to realize high gross margins, etc.), and decisions that led to corporate collaborations or license deals.
Technology Startup
Sponsors: Troutman Pepper
Criteria:
- Company must have been in operation at some point in the period between January 1, 2018 and December 31, 2021.
Key Considerations:
- Product or service innovation including market need or assessment.
- Potential for significant growth.
- The management team and its ability and record of achieving success.
- A demonstration of success such as significant milestones, raising capital, and revenue.
Technology CEO
Sponsor: Cozen O’Connor
Criteria:
- Individual’s background (CV/Bio required) and the company’s success to date.
Key Considerations:
- CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
- Leadership and impact in industry and/or market.
- Ability to attract and retain talent.
- Company milestones including financial accomplishments and a strategy for continued company success.
- Community and/or industry involvement.
- Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the tech industry in the region.
Investment Deal
Sponsor: Baker Tilly
Criteria:
- Deal must have been fully executed between January 1, 2021 and December 31, 2021.
- Events that qualify for this category include Exit Transaction (e.g. IPO), Capital Raising Transaction (e.g. financing: debt, mezzanine, equity; recap), Buy-side or Sell-side of a Merger & Acquisition Transaction.
Key Considerations:
Entries must include a Business and Transaction Narrative/Summary.
Life Sciences & Healthcare Startup
Sponsor: Ben Franklin Technology Partners
Criteria:
- Company must have been in operation at some point in the period between January 1, 2018 and December 31, 2021.
Key Considerations:
- Discuss product innovation including market need/assessment and potential for significant growth.
- Discuss the management team and its ability and record of achieving success.
- Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
- Describe the R&D investment strategy.
- What did the company do to overcome challenges in financing, development or commercialization?
Life Sciences & Healthcare Emerging
Sponsor: RSM US LLP and SAP
Criteria:
- Company must have been in operation before January 1, 2018. Must have sales, grants, or licensing fees. The Company should have no more than 3 years of operating results since its founding.
Key Considerations:
- Describe product, including proprietary applications or other advantage.
- What animal or OUS (outside of the United States) clinical work has been done to prove the technology?
- Describe the impact on the clinical problem this technology is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
- Address the strength of the management team including ability to raise capital.
- Profitability or demonstrated ability to achieve profitability (e.g., strategy to achieve break even, ability to realize high gross margins, etc.) or decisions that led to corporate collaborations or license deals.
Technology Company
Sponsor: Comcast Business
Criteria:
- Company with more than $50 million in revenues in the most recently completed fiscal year.
Key Considerations:
- Leadership and product and/or service innovation in an industry or market.
- Significant company milestones including financial accomplishments.
- Community and industry involvement.
Life Sciences & Healthcare CEO
Sponsors: EY and Morgan Lewis
Criteria:
- Individual’s background (CV/Bio required) and the company’s success to date.
Key Considerations:
- Describe CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
- Leadership and impact in industry and/or market.
- Ability to attract and retain talented resources.
- Company milestones including financial accomplishments and a strategy for continued company success.
- Community/industry involvement.
- Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.
Healthcare Innovator
Sponsor: Independence Blue Cross
Criteria:
- The nominee can be a company, researcher, investor, or individual providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.
Key Considerations:
- The nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth.
- The nominee should be able to demonstrate return on investment or clinical impact of its solution.
- The nominee can be in any sector (technology, life sciences, investment, health care delivery, etc.), but must be serving the healthcare industry in Greater Philadelphia.
- The nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowering costs.
Legend Award (Lifetime Achievement)
Sponsor: Cigniti Technologies
The Legend Award for Lifetime Achievement is presented to an individual who has forwarded technology and sciences in the region through leadership and exemplary work. The Legend recipient must have a strong connection to the community, a history of personal accomplishments and a track record of success.